10-100236962-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_018294.6(CWF19L1):c.1262C>T(p.Pro421Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000139 in 1,435,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018294.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CWF19L1 | NM_018294.6 | c.1262C>T | p.Pro421Leu | missense_variant | 12/14 | ENST00000354105.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CWF19L1 | ENST00000354105.10 | c.1262C>T | p.Pro421Leu | missense_variant | 12/14 | 1 | NM_018294.6 | P1 | |
CWF19L1 | ENST00000478047.1 | n.1417C>T | non_coding_transcript_exon_variant | 3/5 | 2 | ||||
CWF19L1 | ENST00000468709.5 | c.*812C>T | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | 2 | ||||
CWF19L1 | ENST00000482452.5 | c.*649C>T | 3_prime_UTR_variant, NMD_transcript_variant | 10/13 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1435930Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 712536
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.1262C>T (p.P421L) alteration is located in exon 12 (coding exon 12) of the CWF19L1 gene. This alteration results from a C to T substitution at nucleotide position 1262, causing the proline (P) at amino acid position 421 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.